Stifel Nicolaus Keeps Their Buy Rating on Altimmune (ALT)
Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Altimmune (ALT – Research Report) today and set a price target of $18.00. The ...
Stifel Nicolaus Reaffirms Their Buy Rating on Sylogist (SYZ)
In a report released today, Suthan Sukumar from Stifel Nicolaus maintained a Buy rating on Sylogist (SYZ – Research Report), with a price ...
The S&P 500 is officially in a correction. It's the trade war's fault.
The benchmark S&P 500 closed down 10% from its February peak. The whirlwind of tariff announcements in recent weeks have ...
Stifel Ordered by FINRA to Pay $132.5 Million Damages to US Family
(Reuters) - Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family ...